F Berezin

Pharmacologically based dosing of etoposide: a means of safely increasing dose intensity.

Mark J. Ratain, Rosemarie Mick, Richard L. Schilsky et al. · Journal of Clinical Oncology · 1991 · 109 citations

Bone Marrow Function, Dose Intensity, Pharmacotherapy +20

Paradoxical relationship between acetylator phenotype and amonafide toxicity

Mark J. Ratain, Rosemarie Mick, F Berezin et al. · Clinical Pharmacology & Therapeutics · 1991 · 81 citations

Pharmacokinetics and pharmacodynamics of oltipraz as a chemopreventive agent.

E Gupta, Olufunmilayo I. Olopade, Mark J. Ratain et al. · PubMed · 1995 · 64 citations

Chemopreventive Agent, Allergy, Pharmacological Study +11

Phase I study of amonafide dosing based on acetylator phenotype.

Mark J. Ratain, Rosemarie Mick, F Berezin et al. · PubMed · 1993 · 61 citations

Phenotype Category, Molecular Pharmacology, Oncology +14

Individualized dosing of amonafide based on a pharmacodynamic model incorporating acetylator phenotype and gender

Mark J. Ratain, Rosemarie Mick, Linda Janisch et al. · Pharmacogenetics · 1996 · 43 citations